XML 24 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment And Geographic Information
 3 Months Ended
Mar. 31, 2012
Segment And Geographic Information [Abstract]  
Segment And Geographic Information

10. SEGMENT AND GEOGRAPHIC INFORMATION

The Company considers reporting segments in accordance with FASB ASC 280, "Segment Reporting." The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. These devices are developed and marketed to a broad base of medical centers in the United States and internationally. Management considers all such sales to be part of a single reportable segment.

Geographic revenue was as follows:

 

 

     Three Months Ended March 31,  
     2012      2011  

United States

    $ 13,193,464       $ 12,122,543   

International

      4,282,838         3,514,538   
  

 

 

     

 

 

  

Total

    $ 17,476,302       $ 15,637,081   
  

 

 

     

 

 

  

Substantially all of the Company's long-lived assets are located in the United States.